tiprankstipranks

AngioDynamics price target raised to $15 from $14 at H.C. Wainwright

H.C. Wainwright raised the firm’s price target on AngioDynamics (ANGO) to $15 from $14 and keeps a Buy rating on the shares. The company reported a top- and bottom-line beat in fiscal Q2, the analyst tells investors in a research note.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue